Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
听
Also in the Knowledge Center
Scientific Article
/ Apr 16, 2020
Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
Read more
Scientific Article
/ Jan 05, 2020
A multicentre, randomized, double鈥恗asked, parallel group, vehicle鈥恈ontrolled phase IIb study
Read more
Scientific Article